Low-dose cyclosporine for the treatment of crohn's disease

New England Journal of Medicine

Volumn 330, Issue 26, 1994, Pages 1846-1851

  Feagan, Brian G ^d   Mcdonald, John W D ^d   Rochon, James ^d   Laupacis, Andreas ^h   Fedorak, Richard N ^a   Lynfield, Ruth ^h   Kinnear, Douglas ^e   Saibil, Fred ^g   Groll, Aubrey ^c   Archambault, Andre ^f   Gillies, Richard ^h   Valberg, Barbara ^d   Irvine, E Jan ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MESALAZINE; PLACEBO; PREDNISONE;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OSTEOPOROSIS; PARESTHESIA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AMINOSALICYLIC ACIDS; CROHN DISEASE; CYCLOSPORINE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MESALAMINE; PREDNISONE; TREATMENT OUTCOME;

EID: 0028362206     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199406303302602     Document Type: Article

References (32)

1. Summers RW, Switz DM, Sessions JT Jr, National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979; 77: 847-869
2. Malchow H, Ewe K, Brandes JW, European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 249-266
3. Singleton JW, Law DH, Kelly ML Jr, Mekhjian HS, Sturdevant RAL National Cooperative Crohn's Disease Study: adverse reactions to study drugs. Gastroenterology 1979; 77: 870-882
4. Lennard-Jones JE Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease. Dig Dis Sci 1981; 26: 364-368
5. Klein M, Binder HJ, Mitchell M, Aaronson R, Spiro H Treatment of Crohn's disease with azathioprine: a controlled evaluation. Gastroenterology 1974; 66: 916-922
6. Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term efficacy. Ann Intern Med 1989; 111: 641-649
7. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS Treatment of Crohn's disease with 6-mercaptopurine: a long-term, randomized, double-blind study. N Engl J Med 1980; 302: 981-987
8. Rosenberg JL, Levin B, Wall AJ, Kirsner JB A controlled trial of azathioprine in Crohn's disease. Am J Dig Dis 1975; 20: 721-726
9. Willoughby JMT, Kumar PJ, Beckett J, Dawson AM Controlled trial of azathioprine in Crohn's disease. Lancet 1971; 2: 944-947
10. O'Donoghue DP, Dawson AM, Powell-Tuck J, Bown RL, Lennard-Jones JE Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet 1978; 2: 955-957
11. Singleton JW Azathioprine has a very limited role in the treatment of Crohn's disease. Dig Dis Sci 1981; 26: 368-371
12. Tugwell P, Bombardier C, Gent M, Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 1990; 335: 1051-1055
13. Ellis CN, Fradin MS, Messana JM, Cyclosporine for plaque-type psoriasis: results of a multidose, double-blind trial. N Engl J Med 1991; 324: 277-284
14. Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M, Inaba G Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease. Lancet 1989; 1: 1093-1096
15. Brynskov J, Freund L, Rasmussen SN, A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med 1989; 321: 845-850
16. von Graffenried B, Krupp P Side effects of cyclosporine (Sandimmun) in renal transplant recipients and in patients with autoimmune diseases. Transplant Proc 1986; 18: 876-883
17. Palestine AG, Austin HA III, Balow JE, Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med 1986; 314: 1293-1298
18. Bertani T, Ferrazzi P, Schieppati A, Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients. Kidney Int 1991; 40: 243-250
19. Best WR, Becktel JM, Singleton JW, Kern F Jr Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-444
20. Best WR, Becktel JM, Singleton JW Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979; 77: 843-846
21. Irvine EJ, Feagan B, Rochon J, Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology 1994; 106: 287-296
22. Rosano TG, Freed BM, Pell MA, Lempert N Cyclosporine metabolites in human blood and renal tissue. Transplant Proc 1986; 18: Suppl 5: 35-40
23. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.
24. Cox DR Regression models and life-tables. J R Stat Soc [B] 1972; 34: 187-220
25. Jennrich RI, Schluchter MD Unbalanced repeated-measures models with structured covariance matrices. Biometrics 1986; 42: 805-820
26. Hocking RR. The analysis of linear models. Monterey, Calif.: Brooks/Cole, 1985.
27. SAS procedures guide, version 6. 3rd ed. Cary, N.C.: SAS Institute, 1990.
28. Dixon WJ, Brown MB, Engelman L, Hill MA, Jennrich RI. BMDP statistical software manual. Vol. 2. Berkeley: University of California Press, 1988.
29. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, N.J.: Lawrence Erlbaum Associates, 1988.
30. Feutren G, Mihatsch MJ Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992; 326: 1654-1660
31. Hanauer SB, Smith MB Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A. Am J Gastroenterol 1993; 88: 646-649
32. Hawthorne AB, Hawkey CJ Immunosuppressive drugs in inflammatory bowel disease: a review of their mechanisms of efficacy and place in therapy. Drugs 1989; 38: 267-288